Trupanion Inc (NYSE:TRUP) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.

According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

Several other research analysts also recently weighed in on TRUP. RBC Capital Markets set a $18.00 price target on Trupanion and gave the stock a “buy” rating in a research note on Tuesday, September 20th. Stifel Nicolaus upped their price target on Trupanion from $17.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, August 3rd. Finally, Canaccord Genuity restated a “buy” rating and issued a $19.00 price target on shares of Trupanion in a research note on Thursday, August 4th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $16.00.

Analyst Recommendations for Trupanion (NYSE:TRUP)

Shares of Trupanion (NYSE:TRUP) opened at 16.75 on Friday. Trupanion has a 12-month low of $7.61 and a 12-month high of $17.68. The company’s market cap is $489.99 million. The company has a 50-day moving average of $16.12 and a 200 day moving average of $15.19.

Trupanion (NYSE:TRUP) last posted its quarterly earnings results on Tuesday, November 1st. The company reported ($0.06) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.06). The business earned $48.40 million during the quarter, compared to the consensus estimate of $48.17 million. During the same quarter in the previous year, the company earned ($0.17) earnings per share. The company’s revenue for the quarter was up 27.7% compared to the same quarter last year. On average, equities research analysts expect that Trupanion will post ($0.23) EPS for the current year.

In related news, Director Howard E. Rubin sold 21,379 shares of the stock in a transaction on Tuesday, August 30th. The stock was sold at an average price of $14.95, for a total transaction of $319,616.05. Following the sale, the director now owns 146,579 shares in the company, valued at approximately $2,191,356.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Darryl Rawlings sold 3,500 shares of the stock in a transaction on Tuesday, October 4th. The shares were sold at an average price of $16.21, for a total value of $56,735.00. Following the sale, the chief executive officer now owns 1,526,505 shares in the company, valued at approximately $24,744,646.05. The disclosure for this sale can be found here.

A number of hedge funds have recently added to or reduced their stakes in the stock. Capital World Investors raised its stake in Trupanion by 1.5% in the third quarter. Capital World Investors now owns 2,290,500 shares of the company’s stock valued at $38,709,000 after buying an additional 33,000 shares during the last quarter. Immersion Capital LLP acquired a new stake in Trupanion during the second quarter worth $18,374,000. Vanguard Group Inc. raised its stake in Trupanion by 8.1% in the second quarter. Vanguard Group Inc. now owns 545,545 shares of the company’s stock worth $7,228,000 after buying an additional 41,036 shares during the last quarter. BlackRock Fund Advisors raised its stake in Trupanion by 6.1% in the third quarter. BlackRock Fund Advisors now owns 402,866 shares of the company’s stock worth $6,808,000 after buying an additional 23,269 shares during the last quarter. Finally, State Street Corp raised its stake in Trupanion by 50.5% in the second quarter. State Street Corp now owns 199,861 shares of the company’s stock worth $2,650,000 after buying an additional 67,026 shares during the last quarter.

ILLEGAL ACTIVITY WARNING: This piece was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2016/11/25/trupanion-inc-trup-downgraded-by-zacks-investment-research-to-hold.html.

About Trupanion

Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.

5 Day Chart for NYSE:TRUP

Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.